Manabi-aid Co.,Ltd.

As of April 30, 2026, Manabi-aid Co.,Ltd. carries a market capitalization of 1.17B, placing it among publicly traded companies globally. Its enterprise value stands at 732.22M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of April 30, 2026, Manabi-aid Co.,Ltd. has 3.41M shares outstanding.

These figures are as of April 30, 2026.

As of April 30, 2026, Manabi-aid Co.,Ltd. maintains a current ratio of 8.09, meaning it holds 8.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended April 30, 2026.

As of the close on October 22, 2026, Manabi-aid Co.,Ltd.'s stock has declined approximately 42.41% over the past 52 weeks. The 50-day moving average sits at 324.50, while the 200-day moving average is 352.51.

As of April 30, 2026, Manabi-aid Co.,Ltd. holds 459.87M in cash and equivalents against 17.85M in total debt, resulting in a net debt position of -442.02M. Total book value stands at 536.47M, with working capital of 480.74M providing operational flexibility.